These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34072345)

  • 41. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment.
    Majc B; Sever T; Zarić M; Breznik B; Turk B; Lah TT
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118782. PubMed ID: 32554164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition.
    Tripathi S; Levine H; Jolly MK
    Annu Rev Biophys; 2020 May; 49():1-18. PubMed ID: 31913665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum.
    Chakraborty P; George JT; Tripathi S; Levine H; Jolly MK
    Front Bioeng Biotechnol; 2020; 8():220. PubMed ID: 32266244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of Stable Epithelial-Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential.
    Tedja R; Alvero AB; Fox A; Cardenas C; Pitruzzello M; Chehade H; Bawa T; Adzibolosu N; Gogoi R; Mor G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
    Lu W; Kang Y
    Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors.
    Imodoye SO; Adedokun KA; Muhammed AO; Bello IO; Muhibi MA; Oduola T; Oyenike MA
    Front Oncol; 2021; 11():762817. PubMed ID: 34868979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
    Cho ES; Kang HE; Kim NH; Yook JI
    Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell Heterogeneity and Phenotypic Plasticity in Metastasis Formation: The Case of Colon Cancer.
    Teeuwssen M; Fodde R
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
    Lee HM; Hwang KA; Choi KC
    Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker.
    Godin L; Balsat C; Van Eycke YR; Allard J; Royer C; Remmelink M; Pastushenko I; D'Haene N; Blanpain C; Salmon I; Rorive S; Decaestecker C
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32276404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition.
    Subbalakshmi AR; Sahoo S; Manjunatha P; Goyal S; Kasiviswanathan VA; Mahesh Y; Ramu S; McMullen I; Somarelli JA; Jolly MK
    J Biol Eng; 2023 Mar; 17(1):17. PubMed ID: 36864480
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Control of Invasion by Epithelial-to-Mesenchymal Transition Programs during Metastasis.
    Pearson GW
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31083398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β.
    Valcourt U; Carthy J; Okita Y; Alcaraz L; Kato M; Thuault S; Bartholin L; Moustakas A
    Methods Mol Biol; 2016; 1344():147-81. PubMed ID: 26520123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interrogation of Phenotypic Plasticity between Epithelial and Mesenchymal States in Breast Cancer.
    Bhatia S; Monkman J; Blick T; Pinto C; Waltham M; Nagaraj SH; Thompson EW
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31234417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
    Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis.
    Saxena K; Jolly MK; Balamurugan K
    Transl Oncol; 2020 Nov; 13(11):100845. PubMed ID: 32781367
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.